Alzheimer's News Today

Alzheimer's News Today Alzheimer's News Today is a digital news publication dedicated to offering comprehensive daily news coverage of Alzheimer's Disease.
(13)

Data from the A4 study, the first and largest to focus on people who have early signs of Alzheimer’s but no symptoms yet...
08/08/2024

Data from the A4 study, the first and largest to focus on people who have early signs of Alzheimer’s but no symptoms yet, are now available. https://buff.ly/46LA7Lu

Columnist Ray Burow remembers her recently passed mother-in-law, who remained loving and loved during her short-term mem...
08/05/2024

Columnist Ray Burow remembers her recently passed mother-in-law, who remained loving and loved during her short-term memory loss. https://buff.ly/3LPVsJU

Experimental blarcamesine (Anavex 2-73) was able to slow cognitive and functional decline in early Alzheimer’s patients ...
08/01/2024

Experimental blarcamesine (Anavex 2-73) was able to slow cognitive and functional decline in early Alzheimer’s patients over a year, data show. https://buff.ly/4fqspdB

Zunveyl, a new oral mild-to-moderate Alzheimer's therapy, showed bioequivalence to galanotamine but fewer GI issues like...
07/30/2024

Zunveyl, a new oral mild-to-moderate Alzheimer's therapy, showed bioequivalence to galanotamine but fewer GI issues like nausea in studies. https://buff.ly/3YkGZ07

Columnist Ray Burow, reflecting on caregiving for her late mother, ponders if it's sometimes OK to lie to a person with ...
07/29/2024

Columnist Ray Burow, reflecting on caregiving for her late mother, ponders if it's sometimes OK to lie to a person with Alzheimer's disease. https://buff.ly/3WG6MhZ

The use of Montelukast oral film was shown to improve cognition in patients with mild to moderate Alzheimer's in a Phase...
07/25/2024

The use of Montelukast oral film was shown to improve cognition in patients with mild to moderate Alzheimer's in a Phase 2 clinical trial. https://buff.ly/4cYUZRM

The FDA granted regenerative medicine advanced therapy (RMAT) status to experimental cell therapy Lomecel-B for mild Alz...
07/18/2024

The FDA granted regenerative medicine advanced therapy (RMAT) status to experimental cell therapy Lomecel-B for mild Alzheimer’s disease. https://buff.ly/4bMe6gh

Foralumab is an antibody being developed by Tiziana Life Sciences that's designed to block CD3, a protein on the surface...
07/11/2024

Foralumab is an antibody being developed by Tiziana Life Sciences that's designed to block CD3, a protein on the surface of immune T-cells. https://buff.ly/4bMqopa

Eli Lilly's donanemab, now Kisunla, was approved by the U.S. Food and Drug Administration for patients with early sympto...
07/03/2024

Eli Lilly's donanemab, now Kisunla, was approved by the U.S. Food and Drug Administration for patients with early symptomatic Alzheimer’s. https://buff.ly/3RSbxlG

The safety and efficacy of buntanetap therapy are comparable in early Alzheimer’s patients regardless of APOE4 status, p...
06/27/2024

The safety and efficacy of buntanetap therapy are comparable in early Alzheimer’s patients regardless of APOE4 status, per new trial data. https://buff.ly/3RKfXLo

With the high temperatures expected this summer, columnist Ray Burow recalls tips she used to help loved ones with demen...
06/24/2024

With the high temperatures expected this summer, columnist Ray Burow recalls tips she used to help loved ones with dementia handle the heat. https://buff.ly/4cj7E1p

The Phase 2 study will further assess SNK01's safety and its efficacy in about 30 patients who'll receive it every three...
06/20/2024

The Phase 2 study will further assess SNK01's safety and its efficacy in about 30 patients who'll receive it every three weeks up to a year. https://buff.ly/3zjccpO

A decision from the FDA on once-monthly maintenance dosing of Leqembi in early Alzheimer's is expected by Jan. 25, 2025....
06/13/2024

A decision from the FDA on once-monthly maintenance dosing of Leqembi in early Alzheimer's is expected by Jan. 25, 2025. https://buff.ly/4baeBAI

An advisory committee to the U.S. Food and Drug Administration (FDA) unanimously voted in favor of donanemab for early A...
06/13/2024

An advisory committee to the U.S. Food and Drug Administration (FDA) unanimously voted in favor of donanemab for early Alzheimer's. https://buff.ly/3VqFzhx

Columnist Ray Burow can attest to the challenges that sandwich generation caregivers face, but says her children learned...
06/10/2024

Columnist Ray Burow can attest to the challenges that sandwich generation caregivers face, but says her children learned valuable lessons. https://buff.ly/3Vznxuz

There's many ways to help call attention to the estimated 47 million people globally with Alzheimer's disease or dementi...
06/06/2024

There's many ways to help call attention to the estimated 47 million people globally with Alzheimer's disease or dementia. https://buff.ly/4c4sBfY

Buntanetap, a small molecule from Annovis Bio, improved cognitive function in people with mild Alzheimer’s with certain ...
05/30/2024

Buntanetap, a small molecule from Annovis Bio, improved cognitive function in people with mild Alzheimer’s with certain biomarkers. https://buff.ly/3yGD7M2

Otsuka is stopping the development of AVP-786, its experimental therapy to treat agitation in people with Alzheimer’s di...
05/23/2024

Otsuka is stopping the development of AVP-786, its experimental therapy to treat agitation in people with Alzheimer’s disease. https://buff.ly/3KenxK4

As a cancer survivor, columnist Ray Burow considers how her chemotherapy treatment compares to her late mother's experie...
05/20/2024

As a cancer survivor, columnist Ray Burow considers how her chemotherapy treatment compares to her late mother's experience with Alzheimer's. https://buff.ly/3UGicA8

Eisai has started a rolling application seeking U.S. FDA approval of an under-the-skin injection version of Leqembi for ...
05/16/2024

Eisai has started a rolling application seeking U.S. FDA approval of an under-the-skin injection version of Leqembi for early Alzheimer’s. https://buff.ly/3QIIUqr

An FDA advisory committee will hold a June 10 meeting to review data on a clinical trial of potential Alzheimer's treatm...
05/09/2024

An FDA advisory committee will hold a June 10 meeting to review data on a clinical trial of potential Alzheimer's treatment donanemab. https://buff.ly/3QFHe1c

Elecsys Phospho-Tau 217, a blood-based test that can distinguish Alzheimer’s from other disorders, may enable an earlier...
05/02/2024

Elecsys Phospho-Tau 217, a blood-based test that can distinguish Alzheimer’s from other disorders, may enable an earlier disease diagnosis. https://buff.ly/4dnvN7N

BioXcel plans to test BXCL501 for treating agitation in Alzheimer’s disease dementia in patients in nursing and assisted...
04/18/2024

BioXcel plans to test BXCL501 for treating agitation in Alzheimer’s disease dementia in patients in nursing and assisted living facilities. https://buff.ly/3Q77jpy

SNK01, an NK cell therapy by NKGen Biotech, appears safe and well tolerated and may be of cognitive benefit in Alzheimer...
04/11/2024

SNK01, an NK cell therapy by NKGen Biotech, appears safe and well tolerated and may be of cognitive benefit in Alzheimer’s disease. https://buff.ly/43X1Dnz

Taking on caregiving for a loved one with Alzheimer's can seem impossible, says columnist Ray Burow, but only until it's...
04/08/2024

Taking on caregiving for a loved one with Alzheimer's can seem impossible, says columnist Ray Burow, but only until it's done. https://buff.ly/3vxWJkw

Eisai is seeking FDA approval of a monthly maintenance IV regimen of Leqembi for people with early Alzheimer’s disease. ...
04/04/2024

Eisai is seeking FDA approval of a monthly maintenance IV regimen of Leqembi for people with early Alzheimer’s disease. https://buff.ly/3xw0IhL

VY-TAU01, an investigational therapy to prevent tau tangles in Alzheimer’s, was well tolerated and showed promise in pre...
03/28/2024

VY-TAU01, an investigational therapy to prevent tau tangles in Alzheimer’s, was well tolerated and showed promise in preclinical studies. https://buff.ly/3vn7QN5

Being a sole caregiver for a loved one with Alzheimer's is hard work, says columnist Ray Burow, but help and resources a...
03/25/2024

Being a sole caregiver for a loved one with Alzheimer's is hard work, says columnist Ray Burow, but help and resources are available. https://buff.ly/4a8wWOP

Eli Lilly asked the FDA last year to approve donanemab, based on the TRAILBLAZER-ALZ 2 trial that showed it slowed cogni...
03/21/2024

Eli Lilly asked the FDA last year to approve donanemab, based on the TRAILBLAZER-ALZ 2 trial that showed it slowed cognitive decline. https://buff.ly/3Pvsyku

The FDA granted breakthrough device designation to a Quanterix test measuring p-Tau 217 as a predictor of Alzheimer's di...
03/14/2024

The FDA granted breakthrough device designation to a Quanterix test measuring p-Tau 217 as a predictor of Alzheimer's disease. https://buff.ly/3Tyr7Er

Address

5307 E Mockingbird Lane, Fl 5th
Dallas, TX
75206

Telephone

+18009361363

Website

Alerts

Be the first to know and let us send you an email when Alzheimer's News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Alzheimer's News Today:

Videos

We Are Rare. We are BioNews.
We Are Rare. We are BioNews.

Alzheimer's News Today is part of the BioNews family, and 60% of us behind the scenes live with a rare condition. This is why we strive to provide you with trustworthy content, meaningful resources and a safe space. #WeAreRare. We are #BioNews. Learn more: https://bionews.com #RareDiseases #AlzheimersNewsToday #AlzheimersDisease #LivingwithAlzheimersDisease #AlzheimersDiseaseCommunity

Slowing Down Alzheimer’s?
Slowing Down Alzheimer’s?

New Hope for Alzheimer’s
New Hope for Alzheimer’s

Shortcuts

Share

Category

Nearby media companies

Other News & Media Websites in Dallas

Show All

You may also like